Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) Return on invested capital

Solventum Corporation's return on invested capital over the twelve months to 30 June 2026 was 13.4%, down 1.4 percentage points from fiscal 2025 (14.8%). That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 14.8% 8.47
FY2024 6.34% (2.88)
FY2023 9.22% 9.22
FY2022 0.00% —

Return on invested capital against peers

Company Return on invested capital
WST West Pharmaceutical Services, Inc. compare 15.4%
SOLV Solventum Corporation 13.4%
ALGN Align Technology, Inc. compare 10.9%
ATR AptarGroup, Inc. compare 7.82%
COO The Cooper Companies, Inc. compare 3.17%
ALC Alcon compare 2.38%
RGEN Repligen Corporation compare 2.18%
BAX Baxter International Inc. compare −1.27%
AVTR Avantor, Inc. compare −2.09%
Medical Instruments & Supplies industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on SOLV